Analysis Finds TrumpRx Offers Price Savings on Only One Medication

The report suggests that the initiative is limited by design, covering just 0.2% of all federally approved medications in the United States. Researchers found that 17 of the listed drugs have cheaper generic equivalents available elsewhere, while 20 others are priced at levels comparable to existing market alternatives like GoodRx. For the remaining cases, the discounts were already accessible through standard manufacturer coupons.

Beyond the pricing discrepancies, the platform imposes restrictive eligibility requirements. Users cannot be enrolled in any government-funded insurance programs, and they must provide a valid prescription. Because nearly half of uninsured American adults did not see a medical professional in 2023, millions are effectively barred from using the service. Neda Ashtari, associate director of health policy at CAP, argued that the administration is replacing robust health insurance coverage with a government-branded coupon book that fails to provide the relief promised to the public.